4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-424350
Director sold 10,000 shares at an average $114.81 ($1,148,083)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WILSON JAMES N · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-15 | Sale : show line 1 in the form 10b5-1 | −6,654 | $114.48 | $761,717 | 1,057,889 | I |
| 2026-10-15 | Sale : show line 2 in the form 10b5-1 | −3,046 | $115.39 | $351,476 | 1,054,843 | I |
| 2026-10-15 | Sale : show line 3 in the form 10b5-1 | −300 | $116.30 | $34,889 | 1,054,543 | I |
| Open-market sales · 10,000 sh · avg $114.81 · $1,148,083 | ||||||
Loading xslF345X06/ownership.xml…